GSDMD and atherosclerosis: Suppression of GSDMD activation by Z-LLSD-FMK or Z-YVAD-FMK remarkably reduced lesion development in ApoE−/− mice, suggesting that inhibition of GSDMD activation may be a promising strategy for the treatment of atherosclerosis.